Immuno-oncology Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

The report on the global immuno-oncology market provides qualitative and quantitative analysis for the period from 2022 to 2028. The report predicts the global immuno-oncology market to grow with a CAGR of nearly 18% over the forecast period from 2022-2028. The study on immuno-oncology market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2022 to 2028.

The report on immuno-oncology market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global immuno-oncology market over the period of 2022 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global immuno-oncology market over the period of 2022 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

• An increase in the research and development in cancer immunotherapy will be driving the growth of the market
• Increasing utilization in developed countries will drive market growth.

2) Restraints

• High costs as compared to chemotherapy and radiotherapy will hamper the market growth.

3) Opportunities

• The introduction of innovative and advanced treatment options creates new growth opportunities.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global immuno-oncology market is segmented on the basis of type, targets, indication, and end users.

The Global Immuno-oncology Market by Type

• Immune Cell Therapy
• Monoclonal Antibodies
• Checkpoint Inhibitors
• Cytokines
• Cancer Vaccines
• Others

The Global Immuno-oncology Market by Targets

• LAG-3
• Anti-CTLA-4
• MAGE-A3
• VEGF
• HDAC
• Others

The Global Immuno-oncology Market by Indication

• Malignant Tumors
• Benign Tumors
• Others

The Global Immuno-oncology Market by End Users

• Hospitals
• Specialty Clinics
• Others

Company Profiles

The companies covered in the report include

• Bristol Myers Squibb Company
• Novartis AG
• F. Hoffmann-LA Roche Ltd.
• Merck & Co., Inc.
• Regeneron Pharmaceuticals
• GlaxoSmithKline Plc.
• Eli Lilly and Company
• Fresenius Kabi AG
• Pfizer Inc.
• AstraZeneca PLC

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the immuno-oncology market.
2. Complete coverage of all the segments in the immuno-oncology market to analyze the trends, developments in the global market and forecast of market size up to 2028.
3. Comprehensive analysis of the companies operating in the global immuno-oncology market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.